VistaGen Therapeutics, Inc.

VTGN · NASDAQ
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$67,131$119,166$16,638$68,135
Short-Term Investments$13,351$0$0$0
Receivables$0$0$803$2,746
Inventory$0$0$0$0
Other Curr. Assets$1,594$1,506$66$117
Total Curr. Assets$82,076$120,672$17,507$70,998
Property Plant & Equip (Net)$1,811$2,255$2,767$3,076
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$454$726$815$569
Total NC Assets$2,265$2,981$3,582$3,645
Other Assets$0$0$0$0
Total Assets$84,341$123,653$21,089$74,643
Liabilities
Payables$653$1,547$2,473$2,759
Short-Term Debt$561$550$591$433
Tax Payable$0$0$0$0
Deferred Revenue$2,588$0$714$1,244
Other Curr. Liab.$8,810$3,026$796$1,329
Total Curr. Liab.$12,612$5,123$4,574$5,765
LT Debt$948$1,570$2,120$2,605
Deferred Rev, NC$391$0$2,315$1,558
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$2,674$0$0
Total NC Liab.$1,339$4,244$4,435$4,163
Other Liabilities$0$0$0$0
Cap. Leases$1,509$2,120$2,606$3,039
Total Liabilities$13,951$9,367$9,009$9,928
Equity
Pref Stock$0$0$0$0
Common Stock$29$27$7$7
Retained Earnings-$407,632-$356,214-$326,852-$267,604
AOCI$5$0$0$0
Other Equity$477,988$470,473$338,925$332,312
Total Equity$70,390$114,286$12,080$64,715
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$84,341$123,653$21,089$74,643
Net Debt-$65,622-$117,046-$13,927-$65,097